Christopher Gallo, Ph.D. is a director in Sterne Kessler’s Biotechnology & Chemical Practice Group, focusing his practice on patent counseling and post-grant proceedings in the life sciences, biotechnology, and biopharmaceutical spaces, including technologies such as cell and gene therapies, biologics, small molecule drugs, antibodies, molecular diagnostics, synthetic biology, and clean technologies.

Christopher’s experience includes advising clients spanning from early-stage start-ups to large corporations on intellectual property issues arising during product research and development, product clearance, patent portfolio acquisitions, and patent enforcement proceedings. This work has involved developing invalidity, noninfringement, design-around, and enforcement strategies, as well as developing litigation positions and challenges to or defenses for patents in post-grant proceedings in the United States and Europe. Christopher also has significant experience handling patent litigation before federal courts (including litigations brought under the Hatch-Waxman Act) and the United States International Trade Commission. He has additionally represented pharmaceutical companies in responding to Citizen Petitions filed with the United States Food & Drug Administration and in challenging the Food & Drug Administration’s decisions in federal court.

Prior to joining the firm, Christopher gained extensive technical experience working as a postdoctoral fellow at the Johns Hopkins University School of Medicine, where he investigated the role of RNA-protein complexes in regulating fertility and cell fate specification. His research involved cell and molecular biology techniques, as well as the biochemical isolation and purification of RNA-protein complexes. Christopher’s doctoral research focused on the role of nicotinamide in regulating gene silencing and lifespan in yeast.

  • Best Lawyers, “Best Lawyers: Ones to Watch® in America” (2024 – 2023)

  • J.D., The George Washington University Law School
  • Ph.D., Biochemistry and Molecular Genetics, University of Virginia
  • B.S., Biology, Pennsylvania State University

  • District of Columbia
  • Maryland
  • U.S. Court of Appeals for the Federal Circuit
  • U.S. District Court for the District of Columbia
  • U.S. District Court for the District of Maryland
  • United States Patent & Trademark Office

  • American Intellectual Property Law Association
  • PTAB Bar Association
  • The National LGBTQ+ Bar Association

  • Spanish

Related News & Insights

From Christopher M. Gallo, Ph.D.

In the News

May 22, 2024

Law360 Names Attys Who Moved Up The Firm Ranks In Q1

Law360

In the News

January 4, 2024

Sterne Kessler Elects Six New Directors in 2024

The Patent Lawyer

Press Release

January 4, 2024

Sterne Kessler Elects Six New Directors in 2024

Sterne, Kessler, Goldstein & Fox

Firm Announcements

November 15, 2023

Sterne Kessler Scores $83.4M Federal Jury Verdict for TwinStrand Biosciences, Inc.

Sterne, Kessler, Goldstein & Fox

Press Release

November 6, 2023

Sterne Kessler Notches Multiple Rankings in 2024 “Best Law Firms” List

Sterne, Kessler, Goldstein & Fox

In the News

October 11, 2023

DNA Sequencing Patent Survives Guardant PTAB Challenge

Law360

Press Release

August 18, 2022

Seven Sterne Kessler Attorneys Recognized in 2023 Editions of Best Lawyers and Best Lawyers: Ones to Watch

Sterne, Kessler, Goldstein & Fox

Books and Chapters

February 17, 2017

Patent Office Litigation - Second Edition 2017

Thomson Reuters Westlaw Multiple Authors